Celtaxsys 
Welcome,         Profile    Billing    Logout  
 1 Product   1 Disease  1 Product   1 Trial   55 News 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
acebilustat (CTX-4430) / Celtaxsys
COPPS, NCT04662060: COVID-19 Outpatient Pragmatic Platform Study () - Acebilustat Sub-Protocol

Completed
2
120
US
Acebilustat, Placebo
Stanford University
Covid19
05/22
02/23
NCT04662086: COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol

Completed
2
122
US
Acebilustat, Camostat
Stanford University
Covid19
05/22
02/23
HEAL, NCT05203835: Trial of Acebilustat for the Treatment of Upper Arm Lymphedema

Active, not recruiting
2
40
US
Acebilustat, Placebo
Stanford University, Celltaxis LLC
Lymphedema of Upper Arm
09/25
09/25
CTX-4398 / Celtaxsys
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
acebilustat (CTX-4430) / Celtaxsys
COPPS, NCT04662060: COVID-19 Outpatient Pragmatic Platform Study () - Acebilustat Sub-Protocol

Completed
2
120
US
Acebilustat, Placebo
Stanford University
Covid19
05/22
02/23
NCT04662086: COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol

Completed
2
122
US
Acebilustat, Camostat
Stanford University
Covid19
05/22
02/23
HEAL, NCT05203835: Trial of Acebilustat for the Treatment of Upper Arm Lymphedema

Active, not recruiting
2
40
US
Acebilustat, Placebo
Stanford University, Celltaxis LLC
Lymphedema of Upper Arm
09/25
09/25
CTX-4398 / Celtaxsys
No trials found

Download Options